These results indicate that GM-CSF is detected similarly in the earlier and established stages of RA and PsA, and in persistent UA, and that GM-CSF-producing cells are pathogenic CD90+ FAP+ synovial fibroblasts (28), CD90+ activated endothelium (33) and sublining CD163+ macrophages. Here, CD163 is linked to rheumatoid arthritis.